Gene · 248
Papers2,303
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,303
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Evaluation of the clinical practice guidelines and consensuses on calcium and vitamin D supplementation in healthy children using the Appraisal of Guidelines for Research and Evaluation II instrument and Reporting Items for Practice Guidelines in Healthcare statement. | Front Nutr | 2022 | 36238458 | PubTator, text mining | PubMed |
| Exploring 2-Tetradecanoylimino-3-aryl-4-methyl-1,3-thiazolines Derivatives as Alkaline Phosphatase Inhibitors: Biochemical Evaluation and Computational Analysis. | Molecules | 2022 | 36235300 | PubTator, text mining | PubMed |
| Adverse Outcome Pathways Associated with the Ingestion of Titanium Dioxide Nanoparticles-A Systematic Review. | Nanomaterials (Basel) | 2022 | 36234403 | PubTator, text mining | PubMed |
| Outcomes and Reliability of Perforator Flaps in the Reconstruction of Hidradenitis Suppurativa Defects: A Systemic Review and Meta-Analysis. | J Clin Med | 2022 | 36233681 | PubTator, text mining | PubMed |
| Proteomics Profiling of Stool Samples from Preterm Neonates with SWATH/DIA Mass Spectrometry for Predicting Necrotizing Enterocolitis. | Int J Mol Sci | 2022 | 36232903 | PubTator, text mining | PubMed |
| Roles of RIPK3 in necroptosis, cell signaling, and disease. | Exp Mol Med | 2022 | 36224345 | PubTator, text mining | PubMed |
| Defective Human SRP Induces Protein Quality Control and Triggers Stress Response. | J Mol Biol | 2022 | 36210597 | PubTator, text mining | PubMed |
| Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC. | Sci Rep | 2022 | 36202941 | PubTator, text mining | PubMed |
| Emerging prediction methods for early diagnosis of necrotizing enterocolitis. | Front Med (Lausanne) | 2022 | 36186788 | PubTator, text mining | PubMed |
| Chitosan - Polyphosphate nanoparticles for a targeted drug release at the absorption membrane. | Heliyon | 2022 | 36177244 | PubTator, text mining | PubMed |
| Applications of human organoids in the personalized treatment for digestive diseases. | Signal Transduct Target Ther | 2022 | 36167824 | PubTator, text mining | PubMed |
| The Burden of Carbohydrates in Health and Disease. | Nutrients | 2022 | 36145184 | PubTator, text mining | PubMed |
| Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells. | Int J Mol Sci | 2022 | 36142793 | PubTator, text mining | PubMed |
| Cellular Concentration of Survivin and Caspase 3 in Habitual Tobacco Chewers with and without Oral Squamous Cell Carcinoma in South Indian Rural Population-A Case Control Study. | Diagnostics (Basel) | 2022 | 36140650 | PubTator, text mining | PubMed |
| Polyoxometalate-based nanocomposites for antitumor and antibacterial applications. | Nanoscale Adv | 2022 | 36133327 | PubTator, text mining | PubMed |
| PROTACs: The Future of Leukemia Therapeutics. | Front Cell Dev Biol | 2022 | 36120561 | PubTator, text mining | PubMed |
| Lipid Messenger Phosphatidylinositol-4,5-Bisphosphate Is Increased by Both PPARα Activators and Inhibitors: Relevance for Intestinal Cell Differentiation. | Biology (Basel) | 2022 | 36101378 | PubTator, text mining | PubMed |
| Cancer Metabolism and Ischemia-Reperfusion Injury: Two Sides of the Same Coin. | J Clin Med | 2022 | 36079025 | PubTator, text mining | PubMed |
| TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial-Mesenchymal Transition and Invasiveness. | Cancers (Basel) | 2022 | 36077674 | PubTator, text mining | PubMed |
| Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response. | Cancers (Basel) | 2022 | 36077645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/248/papers?page=18